CSS
ABBV icon

Cubist Systematic Strategies’s AbbVie ABBV Stock Holding History

Cubist Systematic Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.25M Sell
31,300
-23,600
-43% -$4.81M 0.03% 739
2025
Q2 		$10.2M Buy
54,900
+11,200
+26% +$2.08M 0.05% 592
2025
Q1 		$9.16M Buy
43,700
+16,400
+60% +$3.19M 0.06% 522
2024
Q4 		$4.85M Buy
27,300
+11,300
+71% +$2.08M 0.03% 857
2024
Q3 		$3.16M Buy
16,000
+6,000
+60% +$1.12M 0.02% 1136
2024
Q2 		$1.72M Buy
10,000
+800
+9% +$133K 0.01% 1425
2024
Q1 		$1.68M Sell
9,200
-56,100
-86% -$9.67M 0.01% 1792
2023
Q4 		$10.1M Sell
65,300
-27,600
-30% -$4.02M 0.07% 443
2023
Q3 		$13.8M Buy
92,900
+14,500
+18% +$2.13M 0.1% 236
2023
Q2 		$10.6M Sell
78,400
-39,700
-34% -$5.82M 0.07% 409
2023
Q1 		$18.8M Sell
118,100
-17,000
-13% -$2.6M 0.11% 175
2022
Q4 		$21.8M Buy
135,100
+69,400
+106% +$10.6M 0.13% 131
2022
Q3 		$8.82M Buy
65,700
+34,100
+108% +$4.89M 0.05% 578
2022
Q2 		$4.84M Buy
+31,600
New +$4.83M 0.03% 1021

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's ABBV Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 478,201 shares — an estimated $97.4M sold.

Cubist Systematic Strategies first reported a position in ABBV in Q2 2014 and held it in 37 quarters. The position peaked at $88.8M in Q2 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 478,201 AbbVie shares in Q3 2025, an estimated $97.4M.
  • Cubist Systematic Strategies first reported a position in AbbVie in Q2 2014 and held it in 37 quarters.
  • Cubist Systematic Strategies's AbbVie position peaked at $88.8M in Q2 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.